✦ LIBER ✦

VARC Consensus Report: The FDA Perspective

✍ Scribed by Matthew G. Hillebrenner; Julie A. Swain; Bram Zuckerman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toxicity Testing: The FDA Perspective

✍ JANE E. HENNEY 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

QT interval shortening in spontaneous re

✍ Emanuel Raschi; Elisabetta Poluzzi; Ariola Koci; Giuseppe Boriani; Fabrizio De P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB

Endovascular brachytherapy: The FDA's pe

✍ Tara A. Ryan 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Patient-Reported Outcomes to Support Med

✍ Donald L. Patrick; Laurie B. Burke; John H. Powers; Jane A. Scott; Edwin P. Rock 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

The FDA perspective on the development o

✍ Wilson H. De Camp 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 723 KB

THE FDA REPORT ON INTRAOCULAR LENSES

✍ MD, WALTER J. STARK ;MD, DAVID M. WORTHEN ;MD, JACK T. HOLLADAY ;MD, PATRICIA E. 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 615 KB